AI Analysis
AI-generated analysis. Always verify with the original filing.
Precipio delivered strong top-line growth and significantly narrowed losses in FY2025, progressing toward operational scale as it targets sustained profitability.
Key Takeaways
1Revenue rose 29.8% year-over-year to $24.0M in FY2025, driven by higher diagnostic case volume that supports fixed cost leverage.
2Gross profit grew 41.6% year-over-year to $10.7M, delivering a FY2025 gross margin of 44.5%.
3Operating loss narrowed 71.5% year-over-year to -$1.2M, reflecting improved operational efficiency from expanded case throughput.
4Net loss shrank 91.5% year-over-year to -$363K, with diluted EPS improving to -$0.23 from -$2.93 in FY2024.
5FY2025 free cash flow totalled $359K, calculated as $685K in net operating cash flow less $326K in capital expenditures.
6Management expects further margin improvements from expanded case volume to unlock additional laboratory economies of scale.